| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/09/1997 | WO1997000890A1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient |
| 01/09/1997 | WO1997000889A1 Peptides binding to low-density lipoproteins |
| 01/09/1997 | WO1997000886A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2224867A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | CA2224691A1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | CA2224434A1 Compounds with growth hormone releasing properties |
| 01/08/1997 | EP0752425A2 Peptide ligands for the constant region of immunoglobulins |
| 01/08/1997 | EP0752103A1 Methods for detecting calpain activation and indentifying calpain inhibitors |
| 01/08/1997 | EP0751961A1 Eating suppressant peptides |
| 01/08/1997 | EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751954A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 01/08/1997 | EP0751953A1 Neuropeptides and their use as insecticides |
| 01/08/1997 | EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
| 01/08/1997 | EP0273928B1 A PROTEIN ACTIVE IN HUMORAL HYPERCALCEMIA OF MALIGNANCY-PTHrP |
| 01/08/1997 | CN1139933A Interleukin-6 (iL-6) antagonists |
| 01/08/1997 | CN1139931A Cyclic neurokinin a antagonists |
| 01/07/1997 | US5591822 Hydrophobic attachment site for adhesion peptides |
| 01/07/1997 | US5591714 Derivatives of A82846 |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591572 Aids, hiv |
| 01/03/1997 | WO1997000270A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 01/03/1997 | WO1997000267A1 Conformationally-restricted combinatorial library composition and method |
| 01/03/1997 | CA2361012A1 Conformationally-restricted combinatorial library composition and method |
| 01/03/1997 | CA2221981A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 01/02/1997 | EP0751220A1 Highly purified protein, production and use thereof |
| 01/02/1997 | EP0751219A1 Platelet aggregation inhibitors |
| 01/02/1997 | EP0751149A2 Phenylalanine substitution analogues of magainin peptides |
| 01/02/1997 | EP0751148A2 D-amino acid substitution analogues of Magainin peptides |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750632A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 01/02/1997 | EP0750630A1 Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
| 01/02/1997 | EP0750610A1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis |
| 01/02/1997 | EP0750508A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 01/02/1997 | EP0750506A1 Broad spectrum antimicrobial compounds and methods of use |
| 01/02/1997 | EP0477295B1 Platelet aggregation inhibitors |
| 12/31/1996 | US5589460 Modification of melanotrophic release inhibiting factor |
| 12/31/1996 | US5589459 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| 12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | US5589356 Cyclization |
| 12/31/1996 | US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes |
| 12/31/1996 | CA1338824C Hypoglycemic and growth-promoting agent isolated from bacitracin |
| 12/27/1996 | WO1996041815A2 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 12/27/1996 | WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors |
| 12/27/1996 | EP0750041A2 HIV-2 nucleotide sequences |
| 12/27/1996 | EP0749979A2 Method and composition for treating thrombosis |
| 12/27/1996 | EP0749443A1 Fk-506 cytosolic binding protein |
| 12/27/1996 | EP0749325A1 Bispecific molecules having clinical utilities |
| 12/24/1996 | US5587468 High affinity nucleic acid ligands to HIV integrase |
| 12/24/1996 | US5587462 Corticotropin releasing factor; stimulates the secretion and biosynthesis of acth |
| 12/24/1996 | US5587456 Hydrophobic attachment site for adhesion peptides |
| 12/24/1996 | US5587388 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof |
| 12/19/1996 | WO1996041180A1 Anchor libraries and identification of peptide binding sequences |
| 12/19/1996 | WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 12/19/1996 | WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 12/19/1996 | WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 12/19/1996 | WO1996040894A1 Treatment of insulin resistance |
| 12/19/1996 | WO1996040781A1 CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION |
| 12/19/1996 | WO1996040779A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |
| 12/19/1996 | WO1996040770A2 Anti-fungal d-amino acid histatin-based peptides |
| 12/19/1996 | WO1996040768A2 Anti-fungal and anti-bacterial histatin-based peptides |
| 12/19/1996 | WO1996040758A1 Process for recovering water-insoluble compounds from a fermentation broth |
| 12/19/1996 | WO1996040757A2 Lhrh antagonist peptides |
| 12/19/1996 | WO1996040756A1 Radiometal-binding analogues of leutenizing hormone releasing hormone |
| 12/19/1996 | WO1996040755A1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| 12/19/1996 | WO1996040753A1 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis |
| 12/19/1996 | WO1996040752A1 Novel dolastatin derivatives, their preparation and use |
| 12/19/1996 | WO1996040751A1 Novel dolastatin derivatives, their preparation and use |
| 12/19/1996 | WO1996040750A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 12/19/1996 | WO1996040749A1 Compounds and peptides that bind to the erythropoietin receptor |
| 12/19/1996 | WO1996040637A1 Stable reagents for the preparation of radiopharmaceuticals |
| 12/19/1996 | WO1996040627A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 12/19/1996 | WO1996040293A1 Structurally determined metallo-constructs and applications |
| 12/19/1996 | WO1996040251A1 Prevention and treatment of sepsis |
| 12/19/1996 | WO1996040227A1 Tumor associated epitopes |
| 12/19/1996 | WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 12/19/1996 | WO1996040208A1 Novel mu opioid receptor ligands: agonists and antagonists |
| 12/19/1996 | WO1996040207A1 Novel peptide inhibitors of calmodulin |
| 12/19/1996 | WO1996040206A1 Novel kappa receptor selective opioid peptides |
| 12/19/1996 | WO1996040202A1 Synthesis of n-substituted oligomers |
| 12/19/1996 | WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 12/19/1996 | WO1996040196A1 Appetite regulating compositions |
| 12/19/1996 | WO1996040189A1 Peptides and compounds that bind to a receptor |
| 12/19/1996 | WO1996039834A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| 12/19/1996 | WO1996036722A3 Embedded expression of heterologous proteins |
| 12/19/1996 | CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 12/19/1996 | CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 12/19/1996 | CA2228998A1 Prevention and treatment of sepsis |
| 12/19/1996 | CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses |
| 12/19/1996 | CA2223891A1 Treatment of insulin resistance |
| 12/19/1996 | CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies |
| 12/19/1996 | CA2223611A1 Appetite regulating compositions |
| 12/19/1996 | CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 12/19/1996 | CA2223501A1 Novel peptide inhibitors of calmodulin |
| 12/19/1996 | CA2223428A1 Novel mu opioid receptor ligands: agonists and antagonists |
| 12/19/1996 | CA2223183A1 Anchor libraries and identification of peptide binding sequences |
| 12/19/1996 | CA2223143A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |
| 12/19/1996 | CA2222690A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |